The return of the U.S. Senate to Democratic control appears to improvethe chances for passage of a Patients' Bill of Rights, but it could reducechances for real Medicare reform as key Democratic leaders focus on prescriptiondrug legislation instead.
ASLAN Announces Positive Phase 2 Results of Eblasakimab in Dupilumab-Treated Patients With AD
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem Cells
ReV Up Your Vitiligo Treatment Strategies
LC-OCT Demonstrates Potential For Rapid, Effective Visualization of Inflammatory Conditions Across Skin Types
Tristan Hasbargen, PA-C: Closure Types in Mohs Surgery and More